UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

MicroRNA‐21 protects against cardiac hypoxia/reoxygenation injury by inhibiting excessive autophagy in H9c2 cells via the Akt/mTOR pathway

Journal of cellular and molecular medicine, 2017-03, Vol.21 (3), p.467-474

2017

Volltextzugriff (PDF)

Curcumin Represses NLRP3 Inflammasome Activation via TLR4/MyD88/NF-κB and P2X7R Signaling in PMA-Induced Macrophages

Frontiers in pharmacology, 2016-10, Vol.7, p.369-369

2016

Volltextzugriff (PDF)

Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia/reperfusion injury

Inflammation research, 2022-02, Vol.71 (2), p.227-241

2022

Volltextzugriff (PDF)

GSDMD Mediates LPS-Induced Septic Myocardial Dysfunction by Regulating ROS-dependent NLRP3 Inflammasome Activation

Frontiers in cell and developmental biology, 2021-11, Vol.9, p.779432-779432

2021

Volltextzugriff (PDF)

Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages

Journal of translational medicine, 2014-09, Vol.12 (1), p.266-266, Article 266

2014

Volltextzugriff (PDF)

LCZ696 Attenuated Doxorubicin-Induced Chronic Cardiomyopathy Through the TLR2-MyD88 Complex Formation

Frontiers in cell and developmental biology, 2021-04, Vol.9, p.654051-654051

2021

Volltextzugriff (PDF)

Inhibition of LncRNA-HRIM Increases Cell Viability by Regulating Autophagy Levels During Hypoxia/Reoxygenation in Myocytes

Cellular physiology and biochemistry, 2018-05, Vol.46 (4), p.1341-1351

2018

Volltextzugriff (PDF)

Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation

Cardiovascular therapeutics, 2022-03, Vol.2022, p.3167959-17

2022

Volltextzugriff (PDF)

lncRNA KCNQ1OT1 Suppresses the Inflammation and Proliferation of Vascular Smooth Muscle Cells through IκBa in Intimal Hyperplasia

Molecular therapy. Nucleic acids, 2020-06, Vol.20, p.62-72

2020

Volltextzugriff (PDF)

Oridonin Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting GSDMD-Mediated Pyroptosis

Genes, 2022-11, Vol.13 (11), p.2133

2022

Volltextzugriff (PDF)

Gasdermin D affects aortic vascular smooth muscle cell pyroptosis and Ang II-induced vascular remodeling

Heliyon, 2023-06, Vol.9 (6), p.e16619-e16619, Article e16619

2023

Volltextzugriff (PDF)

Emodin alleviates LPS‐induced myocardial injury through inhibition of NLRP3 inflammasome activation

Phytotherapy research, 2021-09, Vol.35 (9), p.5203-5213

2021

Volltextzugriff (PDF)

Gasdermin D mediates doxorubicin-induced cardiomyocyte pyroptosis and cardiotoxicity via directly binding to doxorubicin and changes in mitochondrial damage

Translational research : the journal of laboratory and clinical medicine, 2022-10, Vol.248, p.36-50

2022

Volltextzugriff (PDF)

Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes

European journal of pharmacology, 2015-09, Vol.762, p.1-10

2015

Volltextzugriff (PDF)

Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes

Drug design, development and therapy, 2019-01, Vol.13, p.975-990

2019

Volltextzugriff (PDF)

Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes

Biomedicine & pharmacotherapy, 2016-08, Vol.82, p.167-172

2016

Volltextzugriff (PDF)

USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes

Circulation research, 2023-02, Vol.132 (4), p.465-480

2023

Volltextzugriff (PDF)

GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis

Hypertension (Dallas, Tex. 1979), 2022-11, Vol.79 (11), p.2505-2518

2022

Volltextzugriff (PDF)

Macrophage-Derived GSDMD Plays an Essential Role in Atherosclerosis and Cross Talk Between Macrophages via the Mitochondria-STING-IRF3/NF-κB Axis

Arteriosclerosis, thrombosis, and vascular biology, 2024-06, Vol.44 (6), p.1365

2024

Volltextzugriff (PDF)

Tabersonine alleviates obesity‐induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1‐mediated inflammation

Phytotherapy research, 2023-03, Vol.37 (3), p.860-871

2023

Volltextzugriff (PDF)

Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways

Cardiovascular drugs and therapy, 2023-12, Vol.37 (6), p.1131-1141

2023

Volltextzugriff (PDF)

Hsa_circ_0007478 aggravates NLRP3 inflammasome activation and lipid metabolism imbalance in ox-LDL-stimulated macrophage via miR-765/EFNA3 axis

Chemico-biological interactions, 2022-12, Vol.368, p.110195-110195, Article 110195

2022

Volltextzugriff (PDF)

OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3

American Journal of Physiology: Cell Physiology, 2024-02, Vol.326 (2), p.C400

2024

Volltextzugriff (PDF)

Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathway

Phytomedicine (Stuttgart), 2023-01, Vol.108, p.154523-154523, Article 154523

2023

Volltextzugriff (PDF)

Deubiquitinase OTUD6a drives cardiac inflammation and hypertrophy by deubiquitination of STING

Biochimica et biophysica acta. Molecular basis of disease, 2024-04, Vol.1870 (4), p.167061-167061, Article 167061

2024

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(51)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

MicroRNA‐21 protects against cardiac hypoxia/reoxygenation injury by inhibiting excessive autophagy in H9c2 cells via the Akt/mTOR pathway

Curcumin Represses NLRP3 Inflammasome Activation via TLR4/MyD88/NF-κB and P2X7R Signaling in PMA-Induced Macrophages

Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia/reperfusion injury

GSDMD Mediates LPS-Induced Septic Myocardial Dysfunction by Regulating ROS-dependent NLRP3 Inflammasome Activation

Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages

LCZ696 Attenuated Doxorubicin-Induced Chronic Cardiomyopathy Through the TLR2-MyD88 Complex Formation

Inhibition of LncRNA-HRIM Increases Cell Viability by Regulating Autophagy Levels During Hypoxia/Reoxygenation in Myocytes

Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation

lncRNA KCNQ1OT1 Suppresses the Inflammation and Proliferation of Vascular Smooth Muscle Cells through IκBa in Intimal Hyperplasia

Oridonin Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting GSDMD-Mediated Pyroptosis

Gasdermin D affects aortic vascular smooth muscle cell pyroptosis and Ang II-induced vascular remodeling

Emodin alleviates LPS‐induced myocardial injury through inhibition of NLRP3 inflammasome activation

Gasdermin D mediates doxorubicin-induced cardiomyocyte pyroptosis and cardiotoxicity via directly binding to doxorubicin and changes in mitochondrial damage

Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes

Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes

Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes

USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes

GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis

Macrophage-Derived GSDMD Plays an Essential Role in Atherosclerosis and Cross Talk Between Macrophages via the Mitochondria-STING-IRF3/NF-κB Axis

Tabersonine alleviates obesity‐induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1‐mediated inflammation

Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways

Hsa_circ_0007478 aggravates NLRP3 inflammasome activation and lipid metabolism imbalance in ox-LDL-stimulated macrophage via miR-765/EFNA3 axis

OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3

Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathway

Deubiquitinase OTUD6a drives cardiac inflammation and hypertrophy by deubiquitination of STING

Suchergebnisse filtern